Skip to main content

Table 6 Analysis of MSI and MLH1 or MGMT methylation

From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma

Methylated and MSI PTC FTC Benign
N (%) N (%) N (%)
MLH1 24/31 (77%)* 3/4 (75%) 4/9 (44%)
MGMT 38/45 (84%)** 7/8 (87%) 3/8 (37%)
  1. *p = 0.079 compared with the benign group; **p = 0.01.